These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31070079)
21. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681 [TBL] [Abstract][Full Text] [Related]
23. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin. Lee JK; Lee S; Hong SK; Byun SS; Lee SE BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847 [TBL] [Abstract][Full Text] [Related]
25. Ciprofloxacin Resistance: A Review of Patients in East London Undergoing Prostate Biopsy. Turner B; Pati J; Nargund V; Claxton A; Longstaff V; Sarkar S; Green J Urol Nurs; 2016; 36(4):173-82. PubMed ID: 29240328 [TBL] [Abstract][Full Text] [Related]
26. Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy. Chambó RC; Tsuji FH; Yamamoto HA; Jesus CM Int Braz J Urol; 2015; 41(1):46-56. PubMed ID: 25928510 [TBL] [Abstract][Full Text] [Related]
28. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. AlKhateeb SS; AlShammari NA; AlZughaibi MA; Ghazwani YG; Alrabeeah KA; Albqami NM Saudi Med J; 2016 Aug; 37(8):860-3. PubMed ID: 27464862 [TBL] [Abstract][Full Text] [Related]
29. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem. Seitz M; Stief C; Waidelich R; Bader M; Tilki D World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy. Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483 [TBL] [Abstract][Full Text] [Related]
31. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Otrock ZK; Oghlakian GO; Salamoun MM; Haddad M; Bizri AR Infect Control Hosp Epidemiol; 2004 Oct; 25(10):873-7. PubMed ID: 15518032 [TBL] [Abstract][Full Text] [Related]
32. Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy? Altunsoy A; Coşer Ş; Kemirtlek N; Aykanat IC; Balci M; Bodur H; Tuncel A J Infect Dev Ctries; 2024 Apr; 18(4):595-599. PubMed ID: 38728642 [TBL] [Abstract][Full Text] [Related]
33. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. Samarinas M; Dimitropoulos K; Zachos I; Gravas S; Karatzas A; Tzortzis V World J Urol; 2016 Nov; 34(11):1555-1559. PubMed ID: 26951136 [TBL] [Abstract][Full Text] [Related]
34. Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases. Seo YE; Ryu H; Oh JJ; Jeong SJ; Hwang SI; Lee HJ; Hong SK; Byun SS; Lee SE; Lee S Surg Infect (Larchmt); 2018 Oct; 19(7):704-710. PubMed ID: 30227106 [TBL] [Abstract][Full Text] [Related]
35. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis. Liss MA; Kim W; Moskowitz D; Szabo RJ J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415 [TBL] [Abstract][Full Text] [Related]
36. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy. Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy. Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort. Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114 [TBL] [Abstract][Full Text] [Related]
39. Febrile urinary tract infection after prostate biopsy and quinolone resistance. Choi JW; Kim TH; Chang IH; Kim KD; Moon YT; Myung SC; Kim JW; Kim MS; Kwon JK Korean J Urol; 2014 Oct; 55(10):660-4. PubMed ID: 25324949 [TBL] [Abstract][Full Text] [Related]
40. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients. Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]